The second International Federation of Psoriasis Associations (IFPA) Forum in Asia 2023 took place in Singapore beginning of July on the margins of the World Congress of Dermatology. This IFPA Forum was focused on the unmet needs of people living with psoriatic disease in Asia and their solutions. EUROPSO was proudly represented by our President, Jan Koren, two of our Board members, Jaime Melancia from Portugal and Tina Koukopoulou from Greece, along with other individual members.
The Forum was set from the beginning to become a landmark event, bringing together psoriatic patients, medical professionals, researchers, and policymakers from around the world. This biennial gathering, hosted in Asia for the first time, promises to create a platform for shared knowledge, collaboration, and empowerment for the psoriatic patient community. With a focus on hope and innovation, the IFPA Forum 2023 holds immense importance for shaping the future of psoriasis treatment and advocacy worldwide.
Bringing Psoriatic Patients Together
The IFPA Forum serves as a beacon of unity, uniting psoriatic patients from diverse backgrounds and cultures. By fostering a sense of community, attendees find solace in knowing they are not alone in their journey with psoriasis. Patients exchange personal experiences, challenges, and triumphs, while gaining inspiration and motivation to face the condition head-on. To access the IFPA Forum 2023 Briefing Book please click here.
Access to Cutting-Edge Research
One of the central pillars of the IFPA Forum in Asia 2023 is its commitment to disseminating the latest advancements in psoriasis research. Leading dermatologists, researchers, and medical experts present their findings and share insights into emerging treatments and therapies. This invaluable knowledge exchange empowers patients to make informed decisions about their treatment options and provides hope for those seeking relief from the burdens of psoriasis.
Advocacy for Psoriasis Awareness
Beyond its role as a knowledge-sharing platform, the IFPA Forum champions the cause of raising awareness about psoriasis on a global scale. Through symposiums and workshops, participants delve into the various challenges faced by psoriatic patients, including stigma, discrimination, and limited access to healthcare. Armed with newfound knowledge and perspectives, attendees return to their home countries empowered to advocate for improved patient rights and social acceptance.
Pioneering Psoriasis Treatment and Care
The IFPA Forum 2023 fosters a collaborative environment that encourages cross-border cooperation among healthcare professionals and industry stakeholders. This collaborative approach fuels advancements in psoriasis treatment, facilitating the development of novel therapies and patient-centric care models. By embracing a collective commitment to innovation, participants contribute to a brighter future for psoriatic patients worldwide.
Global Impact and Outreach
As Asia takes center stage for the IFPA Forum, its global impact cannot be underestimated. Asia, with its vast population and diverse healthcare systems, presents unique opportunities and challenges in managing psoriasis. By hosting the Forum in Asia, the IFPA expands its reach to regions that may have been underrepresented in previous gatherings, thereby promoting global inclusivity and knowledge sharing.
„The IFPA Forum in Asia 2023 stands as a symbol of hope, unity, and progress for the psoriatic patient community worldwide“ said Jan Koren, EUROPSO President.
By creating an inclusive and collaborative space, this groundbreaking event strives to leave a lasting impact on research, treatment, and advocacy efforts for psoriasis. As patients, healthcare professionals, and advocates come together, they embody the spirit of solidarity, determined to reshape the landscape of psoriasis care and awareness on a global scale.
„The IFPA Forum 2023 is not just an event; it is a catalyst for positive change, forging a path towards a brighter future for all those affected by psoriasis“ concluded Koren.
Featured image credit: IFPA, Twitter